Cookson Peirce & Co’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.66M Sell
102,341
-2,651
-3% -$42.3K 0.06% 157
2026
Q2
$1.78M Sell
104,992
-17,491
-14% -$279K 0.06% 151
2026
Q1
$1.82M Buy
+122,483
New +$1.79M 0.08% 114

Other funds holding AUPH

Cookson Peirce & Co's AUPH Position: Q3 2026 in Review

Cookson Peirce & Co reduced its Aurinia Pharmaceuticals (AUPH) stake by 2.5% in Q3 2026, selling an estimated $42.3K and leaving 102,341 shares worth $1.66M. The position accounts for 0.06% of the portfolio, ranked #157.

Cookson Peirce & Co first reported a position in AUPH in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.82M in Q1 2026. 276 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • Cookson Peirce & Co held 102,341 shares of Aurinia Pharmaceuticals worth $1.66M as of Q3 2026.
  • Cookson Peirce & Co sold 2,651 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $42.3K.
  • Aurinia Pharmaceuticals made up 0.06% of Cookson Peirce & Co's portfolio in Q3 2026, its #157 holding.
  • Cookson Peirce & Co first reported a position in Aurinia Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Cookson Peirce & Co's Aurinia Pharmaceuticals position peaked at $1.82M in Q1 2026.
  • 276 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on Cookson Peirce & Co's 13F filing for Q3 2026, filed 30 Oct 2026.